MORGAN STANLEY - 31 Mar 2025 SCHEDULE 13G Report for Terns Pharmaceuticals, Inc. Common Stock (TERN)

Filing Manager
MORGAN STANLEY
Reporting Manager
Morgan Stanley
Security
Terns Pharmaceuticals, Inc. Common Stock
Symbol
TERN
Shares outstanding
87.7M shares
Disclosed Ownership
7.1M shares
Ownership
8.1%
Form type
SCHEDULE 13G
Filing time
07 May 2025, 11:29:59 UTC
Date of event
31 Mar 2025
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Morgan Stanley 8.1% 7.1M 0 7.1M Chris O'Hara Authorized Signatory, Morgan Stanley
Morgan Stanley Capital Services LLC 7% 6.09M 0 6.09M Chris O'Hara Authorized Signatory, Morgan Stanley Capital Services LLC